Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled DiabetesJunichi Matsubara, Hisao Ogawa, Eiichiro Yamamoto et al.|Circulation Journal|2013Cited by 199